Enzymatica AB (publ)
SSE:ENZY.ST
3.05 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 50.904 | 48.948 | 57.243 | 111.245 | 61.306 | 52.56 | 59.446 | 36.482 | 27.912 | 19.063 | 10.489 | 0.895 | 0.582 | 0 |
| Cost of Revenue
| 19.041 | 20.494 | 23.891 | 35.286 | 16.409 | 15.756 | 23.117 | 14.253 | 8.486 | 4.166 | 2.334 | 0.651 | 0.611 | 0.095 |
| Gross Profit
| 31.863 | 28.454 | 33.352 | 75.959 | 44.897 | 36.804 | 36.329 | 22.229 | 19.426 | 14.897 | 8.155 | 0.244 | -0.029 | -0.095 |
| Gross Profit Ratio
| 0.626 | 0.581 | 0.583 | 0.683 | 0.732 | 0.7 | 0.611 | 0.609 | 0.696 | 0.781 | 0.777 | 0.273 | -0.05 | 0 |
| Reseach & Development Expenses
| 15.183 | 26.497 | 24.212 | 22.486 | 28.498 | 20.815 | 14.45 | 12.345 | 7.844 | 5.796 | 2.842 | 0 | 0 | 0 |
| General & Administrative Expenses
| 39.414 | 38.716 | 32.77 | 40.744 | 28.975 | 28.559 | 27.345 | 26.183 | 20.906 | 33.402 | 15.505 | 3.326 | 2.585 | 0 |
| Selling & Marketing Expenses
| 28.371 | 32.784 | 22.653 | 25.777 | 30.165 | 29.236 | 29.279 | 31.135 | 31.203 | 26.968 | 13.493 | 0 | 0 | 0.092 |
| SG&A
| 67.785 | 71.5 | 55.423 | 66.521 | 59.14 | 57.795 | 56.624 | 57.318 | 52.109 | 33.402 | 15.505 | 3.326 | 2.585 | 0.092 |
| Other Expenses
| -3.043 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 79.925 | 96.672 | 78.599 | 88.021 | 86.556 | 77.385 | 66.539 | 68.406 | 59.944 | 47.564 | 24.364 | 7.915 | 4.89 | -0.02 |
| Operating Income
| -48.062 | -68.217 | -45.247 | -12.062 | -41.66 | -40.581 | -30.21 | -46.177 | -40.518 | -32.667 | -16.209 | -7.671 | -4.919 | -0.075 |
| Operating Income Ratio
| -0.944 | -1.394 | -0.79 | -0.108 | -0.68 | -0.772 | -0.508 | -1.266 | -1.452 | -1.714 | -1.545 | -8.571 | -8.452 | 0 |
| Total Other Income Expenses Net
| -1.657 | -0.53 | -0.453 | -1 | -0.28 | -1.569 | -0.659 | -0.655 | -0.312 | 0.274 | 0.001 | 0.103 | -0.068 | -0.115 |
| Income Before Tax
| -49.719 | -68.747 | -45.7 | -13.062 | -41.94 | -42.15 | -30.869 | -46.831 | -40.83 | -32.393 | -16.208 | -7.568 | -4.987 | -0.19 |
| Income Before Tax Ratio
| -0.977 | -1.404 | -0.798 | -0.117 | -0.684 | -0.802 | -0.519 | -1.284 | -1.463 | -1.699 | -1.545 | -8.456 | -8.569 | 0 |
| Income Tax Expense
| 0.009 | -0.089 | -0.307 | 0.159 | -0.961 | 0.429 | 0.576 | -1.826 | -0.544 | 0.472 | 0.031 | 0.135 | 0.001 | 0 |
| Net Income
| -49.728 | -68.657 | -45.393 | -13.221 | -40.979 | -42.579 | -31.445 | -45.006 | -40.83 | -32.393 | -16.208 | -7.568 | -4.987 | -0.19 |
| Net Income Ratio
| -0.977 | -1.403 | -0.793 | -0.119 | -0.668 | -0.81 | -0.529 | -1.234 | -1.463 | -1.699 | -1.545 | -8.456 | -8.569 | 0 |
| EPS
| -0.28 | -0.44 | -0.31 | -0.093 | -0.29 | -0.45 | -0.35 | -0.68 | -1.44 | -1.25 | -0.79 | -0.41 | -0.39 | -0.007 |
| EPS Diluted
| -0.28 | -0.44 | -0.31 | -0.093 | -0.29 | -0.45 | -0.35 | -0.68 | -1.44 | -1.25 | -0.79 | -0.41 | -0.39 | -0.007 |
| EBITDA
| -41.122 | -59.972 | -38.185 | -5.228 | -33.391 | -33.581 | -24.978 | -42.608 | -40.385 | -31.802 | -16.043 | -7.548 | -4.9 | -0.073 |
| EBITDA Ratio
| -0.808 | -1.225 | -0.667 | -0.047 | -0.563 | -0.658 | -0.42 | -1.253 | -1.447 | -1.658 | -1.527 | -8.398 | -8.419 | 0 |